Next Generation Bioprinting Market Size, Share, and Trends 2024 to 2034

The next generation bioprinting market size. Global industry analysis, size, share, growth, trends, regional outlook, and forecast 2025-2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 5560
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis 
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on The Next Generation Bioprinting Market 

5.1. COVID-19 Landscape: Next Generation Bioprinting Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Next Generation Bioprinting Market, By Technology Type

8.1. Next Generation Bioprinting Market Revenue and Volume, by Technology Type
8.1.1 Laser-Based Technology
8.1.1.1. Market Revenue and Volume Forecast 
8.1.2. Extrusion Based Technology 
8.1.2.1. Market Revenue and Volume Forecast 
8.1.3. Inkjet-Based Technology
8.1.3.1. Market Revenue and Volume Forecast 
8.1.4. Others 
8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Next Generation Bioprinting Market, By Application

9.1. Next Generation Bioprinting Market Revenue and Volume, by Application
9.1.1. Biomedical Applications 
9.1.1.1. Market Revenue and Volume Forecast 
9.1.2. Others 
9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Next Generation Bioprinting Market, By End-User

10.1. Next Generation Bioprinting Market Revenue and Volume, by End-User
10.1.1. Pharmaceuticals and Biotechnology Companies
10.1.1.1. Market Revenue and Volume Forecast 
10.1.2. Academic Research and Development

Chapter 11. Global Next Generation Bioprinting Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Technology Type 
11.1.2. Market Revenue and Volume Forecast, by Application 
11.1.3. Market Revenue and Volume Forecast, by End-User 
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Technology Type 
11.1.4.2. Market Revenue and Volume Forecast, by Application 
11.1.4.3. Market Revenue and Volume Forecast, by End-User 
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Technology Type 
11.1.5.2. Market Revenue and Volume Forecast, by Application 
11.1.5.3. Market Revenue and Volume Forecast, by End-User 
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Technology Type 
11.2.2. Market Revenue and Volume Forecast, by Application 
11.2.3. Market Revenue and Volume Forecast, by End-User 
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Technology Type 
11.2.4.2. Market Revenue and Volume Forecast, by Application 
11.2.4.3. Market Revenue and Volume Forecast, by End-User 
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Technology Type 
11.2.5.2. Market Revenue and Volume Forecast, by Application 
11.2.5.3. Market Revenue and Volume Forecast, by End-User 
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Technology Type 
11.2.6.2. Market Revenue and Volume Forecast, by Application 
11.2.6.3. Market Revenue and Volume Forecast, by End-User 
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Technology Type 
11.2.7.2. Market Revenue and Volume Forecast, by Application 
11.2.7.3. Market Revenue and Volume Forecast, by End-User 
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Technology Type 
11.3.2. Market Revenue and Volume Forecast, by Application 
11.3.3. Market Revenue and Volume Forecast, by End-User 
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Technology Type 
11.3.4.2. Market Revenue and Volume Forecast, by Application 
11.3.4.3. Market Revenue and Volume Forecast, by End-User 
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Technology Type 
11.3.5.2. Market Revenue and Volume Forecast, by Application 
11.3.5.3. Market Revenue and Volume Forecast, by End-User 
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Technology Type 
11.3.6.2. Market Revenue and Volume Forecast, by Application 
11.3.6.3. Market Revenue and Volume Forecast, by End-User 
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Technology Type 
11.3.7.2. Market Revenue and Volume Forecast, by Application 
11.3.7.3. Market Revenue and Volume Forecast, by End-User 
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Technology Type 
11.4.2. Market Revenue and Volume Forecast, by Application 
11.4.3. Market Revenue and Volume Forecast, by End-User 
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Technology Type 
11.4.4.2. Market Revenue and Volume Forecast, by Application 
11.4.4.3. Market Revenue and Volume Forecast, by End-User 
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Technology Type 
11.4.5.2. Market Revenue and Volume Forecast, by Application 
11.4.5.3. Market Revenue and Volume Forecast, by End-User 
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Technology Type 
11.4.6.2. Market Revenue and Volume Forecast, by Application 
11.4.6.3. Market Revenue and Volume Forecast, by End-User 
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Technology Type 
11.4.7.2. Market Revenue and Volume Forecast, by Application 
11.4.7.3. Market Revenue and Volume Forecast, by End-User 
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Technology Type 
11.5.2. Market Revenue and Volume Forecast, by Application 
11.5.3. Market Revenue and Volume Forecast, by End-User 
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Technology Type 
11.5.4.2. Market Revenue and Volume Forecast, by Application 
11.5.4.3. Market Revenue and Volume Forecast, by End-User 
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Technology Type 
11.5.5.2. Market Revenue and Volume Forecast, by Application 
11.5.5.3. Market Revenue and Volume Forecast, by End-User

Chapter 12. Company Profiles

12.1. Academic Research and Development 
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Poietis
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Regenhu
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. 3D Systems, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. GeSiM
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Stratasys
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ROKIT Healthcare
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sculpteo
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Smart3D
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Vivax BIO
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players operating in the global next generation bioprinting market are DirectSync Surgical, Poietis, Regenhu, 3D Systems, Inc., GeSiM, Stratasys, ROKIT Healthcare, Sculpteo, Smart3D, Vivax BIO, Envision Tec, EOS Gmbh Electro Optical System, Materialise NV, Dassault Systemes, Organovo Holdings, Inc, CellLink, Izumi International Inc, Advanced Solutions Life Sciences.LLC., and Others.

The driving factors of the global next generation bioprinting market are the rising prevalence of chronic diseases like heart-related disorders and kidney failures is one of the major growth factors influencing the need for artificial organs, driving the growth of the next generation bioprinting market.

North America region will lead the global global next generation bioprinting market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client